AOD-9604
Also known as: Anti-Obesity Drug (AOD-9604)
At a Glance
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH) and often discussed alongside related fragments such as hGH 176–191. Published evidence in humans is limited and should not be assumed to support effectiveness claims without primary-source review.
⚠️ Research Status: AOD-9604 is not an approved medication. This page summarizes the literature at a high level and intentionally does not include protocols/dosing.
Mechanism of Action (TBD)
Mechanistic framing is typically described relative to hGH C-terminal fragments rather than full-length GH physiology. Claims and proposed pathways should be treated as hypothesis until supported by primary data.
Evidence Summary
Low Confidence Review >10 YearsOne review-style overview of AOD-9604 is available in the investigational-drugs literature. [PMID: 15134286]
Safety & Unknowns
- Published human safety data are limited and fragmented in accessible sources.
- Quality control and identity are key concerns for research-grade materials.
Regulatory Status
| Region | Status |
|---|---|
| United States (FDA) | Not approved |
| European Union (EMA) | Not approved |
| WADA | Check current list (status may change) |
Related Compounds
- Frag 176-191: Parent/related hGH fragment discussed alongside AOD-9604
Changelog
| Date | Change |
|---|---|
| 2026-01-23 | Added dossier and linked primary literature |